Literature DB >> 9723158

Binding of influenza and paramyxoviruses to Group B Streptococcus with the terminal sialyl-galactose linkage.

Y Hosaka1, K Kuroda, A Ikeura, T Iwamoto, Y Suzuki.   

Abstract

Using the virus-binding assay and scanning electron microscopy (SEM), influenza A and B type viruses and two paramyxoviruses, parainfluenza (Sendai) and mumps viruses, were found to bind to Group B Streptococcus (GBS), type Ia and II, with the terminal sialyl-galactose linkage, although some viruses detached during the sample processing for SEM, and mumps virus did not bind to GBSIa. Binding of viruses eluted from GBS at 37 degrees C depended on combination of virus and GBS. The biological significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723158     DOI: 10.1093/oxfordjournals.jmicro.a023574

Source DB:  PubMed          Journal:  J Electron Microsc (Tokyo)        ISSN: 0022-0744


  3 in total

1.  Functional properties and genetic relatedness of the fusion and hemagglutinin-neuraminidase proteins of a mumps virus-like bat virus.

Authors:  Nadine Krüger; Markus Hoffmann; Jan Felix Drexler; Marcel Alexander Müller; Victor Max Corman; Christian Sauder; Steven Rubin; Biao He; Claes Örvell; Christian Drosten; Georg Herrler
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

2.  The Amino Acid at Position 8 of the Proteolytic Cleavage Site of the Mumps Virus Fusion Protein Affects Viral Proteolysis and Fusogenicity.

Authors:  Sarah Hüttl; Markus Hoffmann; Torsten Steinmetzer; Christian Sauder; Nadine Krüger
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

3.  Capsular sialic acid of Streptococcus suis serotype 2 binds to swine influenza virus and enhances bacterial interactions with virus-infected tracheal epithelial cells.

Authors:  Yingchao Wang; Carl A Gagnon; Christian Savard; Nedzad Music; Mariela Srednik; Mariela Segura; Claude Lachance; Christian Bellehumeur; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2013-09-30       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.